Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

The Red Hat Acquisition Could Do Wonders for IBM Stock

By Chris Lau, InvestorPlace Contributor

Markets are fretting over IBM's Red Hat acquisition, but this could be the magic bullet that sets IBM stock on a new growth path.

General Motors Stock Is a Bargain After Restructuring

By Chris Lau, InvestorPlace Contributor

General Motors is still a deep value play. The company's cost cuts will position GM stock toward high-growth automotive markets.

Investors May Be Underestimating Activision Stock

By Chris Lau, InvestorPlace Contributor

ATVI has fallen 40% from its 52-week highs, but ATVI stock has potential catalysts that could enable it to recover.

Pfizer Stock Has Multiple Positive Catalysts

By Chris Lau, InvestorPlace Contributor

Pfizer stock could be boosted by the company's rising investments and strong pipeline. PFE stock would be attractive on a major drop.

Buy Boring Cisco Systems as Market Uncertainties Grow

By Chris Lau, InvestorPlace Contributor

Cisco stock has many positive growth catalysts. Even a tariff war won't meaningfully hurt the outlook of CSCO stock..

Load More